Centocor ( CNTO ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Centocor ( CNTO )

CNTO 0.00001000

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Douglas Babbin who wrote (867)	12/9/1998 9:39:00 PM
From: FNS	Read Replies (1) of 965

Douglas: Re: <<He didn't believe the old Remicade formulation was much of an issue to many investors.>> The person from INVESTOR RELATIONS should have his mouth washed out with soap! He should not be making that kind of personal statement as a CNTO representative...he simply doesn/t KNOW how the many investors felt about the old Remicade/new Remicade reaction screwup! Consequently, Remicade ESTIMATES were lowered. News about the 'dear doctor letter' was suppressed and now this statement...such PR nonsense! (IMHO) (I wonder whether CNTO will follow through on te FDA application re. REMICADE for RA as previously stated? Last I heard study results were halted!!! Comments anyone?) On the other hand, the stock has now digested this mess and should get on with some X's up, I hope.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next